Header cover image

Hong Kong Healthcare Dividend Powerhouses (3%+ Yield)

Results

3

0 new

This screener pinpoints dividend all-stars that boast strong fundamentals with yields typically exceeding 3%.

3 companies

Guangzhou Baiyunshan Pharmaceutical Holdings

Market Cap: HK$42.9b

Researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People’s Republic of China and internationally.

874

HK$16.78

7D

5.4%

1Y

-14.5%

Sinopharm Group

Market Cap: HK$56.0b

Engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People’s Republic of China.

1099

HK$17.96

7D

1.5%

1Y

-8.1%

Chaoju Eye Care Holdings

Market Cap: HK$1.8b

Owns and operates a network of ophthalmic hospitals and optical centers in China.

2219

HK$2.57

7D

3.2%

1Y

-30.0%